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Although somatic cell nuclear transfer (SCNT) and
induction of pluripotency (to form iPSCs) are both
recognized reprogramming methods, there has
been relatively little comparative analysis of the
resulting pluripotent cells. Here, we examine the
capacity of these two reprogramming approaches
to rejuvenate telomeres using late-generation telo-
merase-deficient (Terc/) mice that exhibit telomere
dysfunction and premature aging. We found that
embryonic stem cells established from Terc/
SCNT embryos (Terc/ ntESCs) have greater differ-
entiation potential and self-renewal capacity than
Terc/ iPSCs. Remarkably, SCNT results in exten-
sive telomere lengthening in cloned embryos and
improved telomere capping function in the estab-
lished Terc/ ntESCs. In addition, mitochondrial
function is severely impaired in Terc/ iPSCs and
their differentiated derivatives but significantly
improved in Terc/ ntESCs. Thus, our results sug-
gest that SCNT-mediated reprogramming mitigates
telomere dysfunction and mitochondrial defects to
a greater extent than iPSC-based reprogramming.
Understanding the basis of this differential could
help optimize reprogramming strategies.
INTRODUCTION
Telomeres play key roles in maintaining chromosome stability
and cell replicative capacity (d’Adda di Fagagna et al., 2003;
Hande et al., 1999). Telomere length is primarily maintained
by telomerase, a ribonucleoprotein consisting of telomerase
transcriptase (TERT) and RNA template (TERC) (Greider and
Blackburn, 1985, 1987; Yu et al., 1990). During preimplantation
development, the telomeres lengthen significantly via a telome-
rase-independent mechanism known as alternative lengtheningof telomeres (ALT), while telomerase activity remains very low.
During the transition from the morula to the blastocyst stage,
the mechanism of telomere elongation switches from ALT to a
telomerase-dependent manner, and the telomere length does
not elongate significantly after the blastocyst stage (Liu et al.,
2007). Thus, telomere length is thought to be established during
the early embryonic stage through the ALTmechanism and to be
subsequently maintained by telomerase activity. Progressive
telomere shortening due to absent or insufficient telomerase
activity can eventually lead to loss of telomere capping function,
which plays important roles in driving degenerative pathologies
in humans (Sahin and Depinho, 2010).
Induced pluripotent stem cells (iPSCs) hold great promise in
future clinical applications, especially in the treatment of degen-
eration disorders caused by aging. However, the inferior quality
of iPSCs, especially derived from patients with premature age-
related pathologies, raises significant concerns regarding iPSC
safety (Andrade et al., 2012; Batista et al., 2011). Particularly in
the context of telomere dysfunction and DNA damage, the resul-
tant activated p53 significantly suppresses nuclear reprogram-
ming, while the absence or mutation of p53 provokes genomic
aberrations and tumor formation (Hong et al., 2009; Kawamura
et al., 2009;Mario´n et al., 2009a). Moreover, insufficient telomere
lengthening remains a general problem in both human and
mouse iPSCs (Marion et al., 2009b; Vaziri et al., 2010). Therefore,
telomere elongation during somatic cell reprogramming is of
great importance in the acquisition of authentic pluripotency.
It is well accepted that oocytes have the capacity to elongate
telomeres via the ALT mechanism (Liu et al., 2007). Indeed,
oocyte-derived factor Zscan4 dramatically elongates telomeres
during iPSC induction and thus improves the reprogramming
efficiency and the quality of iPSCs (Jiang et al., 2013). Further-
more, it has been reported previously that telomeres can be
elongated in the cloned animals, even in the case that senescent
cells were used as donor cells for SCNT (Lanza et al., 2000;
Wakayama et al., 2000). Therefore, we speculate that SCNT
utilizing factors in oocytes to reprogram somatic cells may reju-
venate cells with dysfunctional telomeres in amanner superior to
that of iPSC technology with only a few reprogramming factors.
Terc/ mice provide a model of telomere-driven prematureCell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc. 27
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human premature aging pathologies (Blasco, 2005; Herrera
et al., 1999b; Rudolph et al., 1999; Sahin and Depinho, 2010).
Terc/ mice can only be bred to four generations in the
C57BL/6 background. In the third generation (G3) Terc/
mice, disease states associated with short telomeres become
evident, with a reduced body size, a decreased life span, and
atrophy of multiple tissues such as small intestine, spleen, and
testicles (Herrera et al., 1999b; Rudolph et al., 1999). In these
affected tissues, dysfunctional telomeres activate p53-depen-
dent checkpoints and subsequently provoke Puma-dependent
cell apoptosis and p21-dependent cell-cycle arrest, causing tis-
sue maintenance disorders (Ferro´n et al., 2004; Sperka et al.,
2012). Recently, mitochondrial compromise as a consequence
of PGC network repression induced by dysfunctional telomeres
has been proposed to be another cause for the decline of tissue
maintenance in Terc/mice (Sahin et al., 2011). Based on these
studies of the underlying molecular mechanism of telomere-
erosion-induced deficiency, we utilized Terc/mice as a model
to compare the differences between SCNT and transcription-
factor-mediated reprogramming of cells with limited telomere
reserve.
We established embryonic stem cells from Terc/ SCNT
embryos (Terc/ ntESCs) and Terc/ iPSCs from G2 and G3
Terc/ somatic cells, respectively. Our study shows that
Terc/ ntESCs exhibit a better self-renewal capacity and
differentiation potential associated with significantly elongated
telomeres and improved mitochondrial function. In contrast,
telomere and mitochondrial defects become further impaired in
the resulting Terc/ iPSCs and are associated with decreased
self-renewal capability and differentiation potential. Interest-
ingly, PGC-1a expression appears to be irrelevant to the mito-
chondrial dysfunction in G3 Terc/ iPSCs. However, failure to
reactivate PGC-1a expression in differentiating G3 Terc/
iPSCs is associated with an impaired in vitro differentiation
ability, which is mitigated in G3 Terc/ ntESCs. Our study sug-
gests that SCNT is superior to iPSCs in reprogramming donor
cells with short telomeres and thus provides valuable information
for future improvements of iPSCs.
RESULTS
Short Telomeres Decrease Reprogramming Efficiency
in the Derivation of Both ntESCs and iPSCs
In the absence of telomerase, telomeres shorten with increasing
generations of Terc/ mice (Herrera et al., 1999b; Rudolph
et al., 1999). To test the ability of SCNT- and transcription-factor-
mediated reprogramming to rejuvenate cells with dysfunctional
telomeres, we established ntESCs and iPSCs from tail-tip fibro-
blasts (TTFs) of agedG2 or G3 Terc/micewith a pure C57BL/6
genetic background. We transferred the nuclei of G2 or G3
Terc/ TTFs into enucleated oocytes to generate G2 or G3
Terc/ ntESCs. Compared with that of wild-type cloned
embryos, the development of Terc/ cloned embryos to
morula/blastocyst stage was significantly reduced (Figure 1A).
The Terc/ cloned embryos were morphologically normal (Fig-
ure 1B). After the blastocysts were plated onto a feeder layer of
mouse embryonic fibroblasts, the outgrowths emerged after
approximately 5 to 10 days (Figure 1C). Terc/ ntESC lines28 Cell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc.were derived with significantly lower efficiency compared with
wild-type ntESC lines. In total, nine G3 Terc/ ntESC lines
were established from 464 cloned embryos (Figure 1A).
With regard to Terc/ iPSCs induction, Terc/ TTFs were
infected by doxycyline (Dox)-controlled Tet-on inducible lentivi-
ruses containing Oct4, Sox2, Klf4, and c-Myc transcription fac-
tors. The reprogramming kinetics of Terc/ iPSC induction
was quite slow. For G3 Terc/ iPSCs, it took at least 25 days
of Dox treatment before the ES-like colonies emerged (Fig-
ure S1A). Approximately 10–20 colonies emerged from 1 3 105
infected G3 Terc/ fibroblasts, and the reprogramming effi-
ciency (0.019%) was significantly lower than that of wild-type
fibroblasts (Figure S1B). In total, 96 colonies were picked and
60 G3 Terc/ iPSC lines were derived from five independent
experiments. Hereafter, we designated G2-G3 Terc/ ntESCs
and iPSCs as G2-G3 ntESCs and iPSCs, respectively.
Despite the slow kinetics and low reprogramming efficiency,
G2-G3 ntESCs and iPSCs showed typical mouse ESC mor-
phology with a compact appearance and a well-defined border
(Figure 1D and S1C). Consistent with previous observations,
we found that the percentage of cells with a normal karyotype
decreased in G3 iPSCs compared with G2 iPSCs (Table S1). In
addition, we observed the same tendency toward a decreased
frequency of normal karyotype in G3 ntESCs compared with
G2 ntESCs (Table S1), indicating that short telomeres exacer-
bate genomic instability during reprogramming in both iPSCs
and ntESCs. We selected cell lines with more than 50% of cells
with a normal karyotype for further analysis. Although a relatively
low percentage of normal karyotypes was observed in Terc/
ntESCs and iPSCs, Terc/ ntESCs and iPSCs exhibited expres-
sion of pluripotent genes at the mRNA and protein levels similar
to wild-type (WT) ESCs (Figures 1E and S1D). Furthermore,
Terc/ ntESCs and iPSCs showed DNA demethylation at the
promoters of Oct4 and Nanog, which are two important tran-
scription factors governing the pluripotent network (Figure 1F).
G3 ntESCs Show Improved Developmental Potential
Compared with G3 iPSCs
To evaluate the developmental potential of telomerase-deficient
iPSCs and ntESCs, we conducted in vivo and in vitro differenti-
ation assays (Figure 2A). High-contribution chimeric mice could
be obtained from G2 ntESCs (Figure 2B and Table S2) while G2
iPSCs, G3 ntESCs, and G3 iPSCs failed to generate viable
chimeric mice, which is consistent with a previous report (Marion
et al., 2009b). We then examined the developmental potential of
G2 iPSCs, G3 ntESCs, and G3 iPSCs by teratoma formation
assay. Histological examination revealed that G2 iPSCs and
G3 ntESCs could give rise to teratomas containing tissues
from three germ layers (Figure 2C). Of notice, none of the 30
G3 iPSC lines with more than 50% of cells with a normal karyo-
type could generate teratomas (Table S3). Considering that telo-
mere dysfunction may impede cell proliferation rate of G3 iPSCs,
we dissected nude mice at different time points after subcutane-
ous injection of G3 iPSCs and no teratomaswere obtained (Table
S3). Although G3 iPSCs lost in vivo differentiation ability, under
in vitro differentiation conditions the differentiating cells derived
from G3 iPSCs showed an upregulation of markers for the three
germ layers (Figure 2D). The above data indicated that Terc/
ntESCs showed better differentiation ability than Terc/ iPSCs.
Figure 1. Establishment and Characterization of Terc–/– ntESCs and iPSCs from G2-G3 Terc–/– Mice
(A) Summary of ntESCs establishment from cloned embryos reconstructed with WT TTFs and Terc/ TTFs. % indicates percentage of reconstructed oocytes.
The percentage of cloned embryos that can develop into morulae/blastocysts is markedly decreased in G3 Terc/ cloned embryos compared with WT cloned
embryos (n = 3; Student’s t test; p < 0.05). G3 Terc/ ntESC derivation efficiency is significantly decreased compared withWT ntESC derivation efficiency (n = 3;
Student’s t test; p < 0.005).
(B) The morphology of Terc/ cloned embryos at the blastocyst stage. Scale bars, 100 mm.
(C) Representative images of the outgrowth morphologies of Terc/ cloned embryos. Scale bars, 40 mm.
(D) Morphology of G2-G3 ntESCs and iPSCs at passage 10. Scale bars, 100 mm.
(E) ImmunostainingofpluripotentmarkersOct4 (green),Sox2 (red),Nanog (green), andSSEA-1 (red) inG2-G3ntESCand iPSC lines.Nuclear stainingbyDAPI (blue).
(F) Bisulfite sequencing shows the methylation state of the promoter regions ofOct4 and Nanog. Open and closed circles indicate unmethylated and methylated
CpGs, respectively. For each gene, 10 samples were sequenced, and each line represents one repeat.
See also Figure S1 and Table S1.
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Figure 2. Terc–/– ntESCs Show Develop-
mental Potential Superior to That of Terc–/–
iPSCs
(A) Summary of the differentiation potential of
Terc/ ntESCs and iPSCs. See Table S2 and
Table S3 for detailed information.
(B) Four-month-old chimeric mice generated from
G2 ntES-1#. Cell passage = 5.
(C) H&E staining shows teratomas generated from
G2 iPSCs and G3 ntESCs forming tissues from the
three germ layers. Upper: G2 iPSCs; lower: G3
ntESCs. Scale bars, 100 mm.
(D) Quantitative PCR analysis shows the upregu-
lation of markers for three germ layers during
in vitro differentiation of G3 iPSCs. Relative mRNA
expression is normalized to b-actin mRNA and is
represented relative to expression in undifferenti-
ated G3 iPSCs as a control, set as 1. The experi-
ments were performed in triplicate (mean ± SD; n =
3; Student’s t test; ***p < 0.001). The primers used
are listed in Table S4.
See also Figure S2, Table S2, Table S3, and
Table S4.
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possible to clone mice from senescent cells (Mizutani et al.,
2008). Based on this finding, we reasoned that a second round
of NT from G3 ntESCs might generate 2-ntESCs with better
developmental potential. To this end, we conducted a second
round of NT from G3 ntES-2#. Of a total of 242 reconstructed
oocytes, 110 developed into morulae/blastocysts, which is
more efficient than the first round of NT (Figure S2A). In total,
35 2-ntESC lines were established. Interestingly, a majority of
these cell lines could generate chimeric mice (Figure S2B). In
addition, we also generated ntESCs from G3 iPS-5#, G3 iPS-
15#, andwe named these cell lines G3 iPS-ntESCs. Interestingly,
we found that G3 iPS-ntESCs can only be derived from early
passage G3 iPSCs (Figure S2A). The differentiation capacity of
these cell lines was tested by teratoma formation and contribu-
tion of chimeric mice. None of these cell lines could generate30 Cell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc.chimeric mice (Table S2). In contrast to
G3 iPSCs, the G3 iPS-ntESCs could give
rise to teratomas with tissues from three
germ layers (Figure S2C and Table S3).
Collectively, these results demonstrate
that the in vivo differentiation defects of
G3 Terc/ iPSCs can be rescued by
SCNT, which implies that the decreased
developmental potential of G3 iPSCs is
not caused by the possible existing ge-
netic alterations acquired either from telo-
merase loss or the process of iPSC
induction.
G3 ntESCs Exhibit Increased
Proliferation and Reduced
Apoptosis Compared with G3 iPSCs
In Terc/ somatic cells, telomere short-
ening induces both cellular senescence
and apoptosis via activation of the p53signaling pathway, which prompted us to assess the impact
of telomere shortening on the proliferation and apoptosis of
ntESCs and iPSCs. G3 iPSCs displayed a marked decline
in the proliferation rate compared with G2 iPSCs, while the
difference between G3 ntESCs and G2 ntESCs was relatively
small (Figure 3A and S3A). The BrdU incorporation assay and
TUNEL staining revealed significantly reduced proliferation
and increased apoptosis levels in G3 iPSCs versus G2 iPSCs
and G3 ntESCs versus G2 ntESCs, indicating that progressive
telomere shortening induced cell cycle arrest and apoptosis
in both iPSCs and ntESCs (Figures S3A and S3B). Notably,
G3 ntESCs showed significantly increased proliferation and
reduced apoptosis compared with G3 iPSCs (Figures 3A–3C).
Interestingly, the difference in proliferative capacity and
apoptosis rate was substantially more significant between
G3 ntESCs and G3 iPSCs (Figures 3B and 3C) than the
Figure 3. G3 ntESCs Exhibit Increased Proliferation and Reduced Apoptosis Compared with G3 iPSCs
(A) Proliferation curves of G2-G3 ntESCs and iPSCs. A total of 53 105 cells were seeded in 6-well plates and counted every 24 hr using a cell counting chamber
(mean ± SD; n = 3; Student’s t test; *p < 0.05, **p < 0.01, ***p < 0.001; cell passage = 10).
(B) Quantification of 5-bromodeoxyuridine (BrdU)-labeled cells by flow cytometry. Cells were cultured in the presence of BrdU for 30 min and then stained with
anti-BrdU fluorescent antibodies and subjected to following flow cytometry analysis (mean ± SD; n = 3; Student’s t test; ***p < 0.001; cell passage = 10).
(C) Cell apoptosis assay using TUNEL staining and flow cytometry. Cells undergoing apoptosis are positive for TUNEL staining (mean ± SD; n = 3; Student’s t test;
***p < 0.001; cell passage = 10).
(D) Quantification of phospho-p53-positive cells using flow cytometry (mean ± SD; n = 3; Student’s t test; ***p < 0.001; cell passage = 10).
(E) Western blot analysis of p21 protein levels in G2-G3 ntESCs and iPSCs at passage 15; a-tubulin was used as a loading control.
See also Figure S3.
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and S3B), possibly due to a greater level of telomere dysfunc-
tion in G3 Terc/ somatic cells. Next, we examined the p53
signaling pathway in G2 or G3 ntESCs and iPSCs. The results
showed that the percentage of p53-positive cells increased
dramatically in both G2 or G3 iPSCs and ntESCs (Figures 3D
and S3C–S3E). Interestingly, the percentage of p53-positive
cells in G3 ntESCs was substantially lower than those in G3
iPSCs (Figures 3D, S3D, and S3E). In line with these data, the
protein levels of p21, a transcriptional target of p53, increased
in both G3 iPSCs and G3 ntESCs, whereas the level of increase
was substantially lower in G3 ntESCs compared with G3 iPSCs
(Figure 3E).Telomeres Lengthen Remarkably in Terc–/– ntESCs, but
Not in Terc–/– iPSCs, during Reprogramming
During reprogramming, the average telomere length can be
maintained in telomerase-deficient iPSCs, suggesting that a
telomerase-independent telomere elongation mechanism exists
in iPSC induction (Marion et al., 2009b; Wang et al., 2012). In
early cleavage embryos, telomeres lengthen remarkably through
a telomerase-independent mechanism (Liu et al., 2007). Thus, it
is interesting to assess whether SCNT-based reprogramming
could activate amore efficient mechanism to elongate telomeres
in the context of telomerase deficiency. To understand the differ-
ence between these two reprogramming strategies in resetting
telomere length in the absence of telomerase, we analyzedCell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc. 31
Figure 4. G3 ntESCs Show Improved Telo-
mere Lengthening and Capping Function
Compared with G3 iPSCs
(A) Relative telomere length expressed as a T/S
ratio by quantitative real-time PCR analysis in-
dicates extensive telomere elongation in Terc/
ntESCs compared with parental TTFs. (mean ±
SD; n = 3; Student’s t test; **p < 0.01, ***p < 0.001;
cell passage = 4).
(B) Relative telomere length expressed as a T/S
ratio by quantitative real-time PCR analysis in-
dicates extensive telomere elongation in G3
Terc/ cloned embryos at the blastocyst stage
compared with parental somatic cells (mean ± SD;
n = 3; Student’s t test; ***p < 0.001).
(C) Telomere length distribution shown as relative
telomere fluorescence intensity (TFU) by Q-FISH
on metaphase spreads. n = 2. Telomere length
is shown as the TFU. The average telomere
length is shown as the average TFU ± SD. Cell
passage = 10.
(D) The frequency of short telomeres by Q-FISH.
A total of 30 metaphases per cell type were used
(mean ± SD; n = 2; Student’s t test; *p < 0.05, **p <
0.01; cell passage = 10).
(E) The frequency of signal free ends by Q-FISH.
A total of 30 metaphases per cell type were used
(mean ± SD; n = 2; Student’s t test; *p < 0.05, **p <
0.01; cell passage = 10).
(F) Quantification of end-to-end fusion events per
metaphase of G3 ntESCs and G3 iPSCs (mean ±
SD; n = 2, three independent cell lines per cell type
and 25 metaphases per cell line in one indepen-
dent experiment; Student’s t test; ***p < 0.001; cell
passage = 10).
(G–K) Representative images of metaphase chro-
mosomes after telomere Q-FISH. Telomeres are
in red; nuclei labeled by DAPI are in blue.
(G) Representative images of G3 TTF metaphase
chromosomes. (H) Representative images of G3
ntESCs metaphase chromosomes. The arrows
indicate a normal chromosome with four telomere
signals. (I) Representative images of G3 iPSC
metaphase chromosomes. The arrows indicate
p-p arm fusions (right panel). (J) Representative
images of G3 iPSCmetaphase chromosomes. q-q
arm fusions (right panel, top) and p-q arm fusions
(right panel, bottom) are shown. (K) Representative
images of G3 iPSC metaphase chromosomes.
The arrows indicate chromosomes with telomere
signal free ends (right panel).
See also Figure S4.
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PCR. The average telomere length as indicated by the T/S ratio
elongated dramatically in Terc/ ntESCs while remaining or
becoming slightly elongated in Terc/ iPSCs compared with
corresponding parental TTFs (Figure 4A). In agreement with
this result, a significant increase in telomere length was detected
in Terc/ SCNT embryos (Figures 4B and S4A). Overall, these
data indicate that the telomerase-independent telomere elonga-
tion mechanism is more efficient in SCNT. Of note, telomeres
shortened quickly in G3 ntESCs during serial cell passages,
reaching a level similar to G3 iPSCs at cell passage 15 (Fig-32 Cell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc.ure S4B), indicating the requirement of a telomerase-dependent
mechanism in the maintenance of telomere length during the
passage of pluripotent stem cells.
G3 ntESCs Show Alleviated Telomere Dysfunction
Compared with G3 iPSCs
To determine whether telomere dysfunction was improved or
worsened in Terc/ ntESCs and iPSCs, quantitative telomere
FISH (Q-FISH) on metaphase spreads was performed for a
detailed analysis of the telomere distribution pattern within cells
(Figures 4C and S4C). The percentage of critically short
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TTFs and was significantly reduced in Terc/ ntESCs (Figures
4C and 4D). Of note, a dramatic shift to critically shorter telo-
meres was detected in G3 iPSCs (Figures 4C and 4D). In addi-
tion, telomere signal free ends indicating telomere uncapping
were remarkably decreased in Terc/ ntESCs but dramatically
increased in Terc/ iPSCs compared with parental Terc/
TTFs (Figures 4E, 4G, 4H, and 4K). Consistent with the above
data, an increase in end-to-end fusion events per metaphase
was detected in G3 iPSCs, suggesting an increased level of
telomere dysfunction (Figures 4F–4K). These data indicate that
although the average telomere length is maintained or even
slightly elongated in Terc/ iPSCs, the telomere capping
function is further impaired due to an increased frequency of crit-
ically short telomeres (Figures 4D and 4E). In contrast, during
SCNT-mediated reprogramming, the telomere average length
was significantly increased, along with significantly enhanced
telomere capping function.
G3 ntESCs Show Alleviated Mitochondrial Dysfunction
Compared with G3 iPSCs
To further elucidate the underlying molecular mechanism of the
improved pluripotency of G3 ntESCs compared with G3 iPSCs,
we performed microarray analyses to profile the transcriptional
networks.Cluster analysis showedamarkedenrichmentof differ-
entially expressed genes related tomitochondria (Figures 5A and
S5A), which reminded us of the dysfunctional mitochondria
observed in G3 Terc/ somatic cells (Sahin et al., 2011).
To assess whether compromised mitochondrial function is
improved after somatic cell reprogramming, we analyzed mito-
chondrial respiration by measuring the rate of oxygen con-
sumption (OCR). The baseline OCR of G3 iPSCs decreased
dramatically, while the baseline OCR of G3 ntESCs was compa-
rable to the level in G2 ntESCs and G2 iPSCs (Figures 5B and
5C). FCCP, a compound that uncouples ATP synthesis from the
electron transport chain, stimulates the maximum mitochondrial
respiration rate. After FCCP injection, a marked increase in
OCR was observed in G2 ntESCs, G2 iPSCs, and G3 ntESCs,
while G3 iPSCs showed very little increase in OCR (Figures 5B
and 5D), suggesting an impaired mitochondrial respiration
capacity. Interestingly, the rate of acid efflux (ECAR), indicative
of glycolysis activity, also decreased remarkably in G3 iPSCs,
whereas G2 ntESCs, G2 iPSCs, and G3 ntESCs displayed levels
similar to that ofWTESCs (FiguresS5BandS5C).Consistentwith
the decreased OCR and ECAR levels, the total ATP content was
reducedmarkedly inG3 iPSCs (Figure 5E).Duringnuclear reprog-
ramming, mitochondrial oxidative metabolism in differentiated
cells is transformed into glycolytic metabolism. To assess the
relative contribution of glycolysis and mitochondria to the total
cellular ATP content, the ATP content was measured in the pres-
ence or absence of oligomycin, an inhibitor of ATP synthetase.
The proportion of mitochondrial contribution to the total cellular
ATP content was markedly elevated in G3 iPSCs, whereas G3
ntESCs showed levels similar to WT ESCs (Figure S5D). In
ESCs,mitochondrial energymetabolismwas relativelyquiescent,
accompanied with an immature morphology and poor cristae,
while in differentiated cells, mitochondrial energy metabolism
was activated and accompanied with an elongated structure
and rich cristae. Themarkedly increasedmitochondrial contribu-tion to the total cellular ATP content prompted us to assessmito-
chondrial morphology in G3 iPSCs and G3 ntESCs. Using cryoe-
lectron microscopy, we observed that the mitochondria in G3
iPSCs were tubular with rich cristae, while the mitochondria in
G3 ntESCs were spherical with immature, poor cristae resem-
bling WT ESCs (Figure 5F). Together, the above data suggest
that although the mitochondrial respiration capacity is lower in
G3 iPSCs, the mitochondria in G3 iPSCs are aberrantly active in
energy metabolism, while the mitochondria in G3 ntESCs are
quiescent, resembling WT ESCs. These data prompted us to
examine the deleterious byproduct of mitochondrial respiration.
Quiescent mitochondria in ESCs can minimize reactive oxy-
gen species (ROS) production and the resulting oxidative stress
(Zhang et al., 2012). Of note, we observed sharply increased
ROS levels in G3 iPSCs (Figure 5G). Excess ROS accumulation
can cause damage to cellular macromolecules. Mitochondrial
DNA (mtDNA) is very susceptible to ROS attack, which prompted
us to analyze mtDNA mutations in G3 iPSCs. As expected,
notable increases in DNA mutations were observed in G3 iPSCs
compared with G3 somatic cells and G3 ntESCs, indicating that
mtDNA mutations accumulated during the process of transcrip-
tion-factor-mediated reprogramming and during the subsequent
iPSC propagation (Figure 5H). In summary, the above data sug-
gest that unlike the quiescent mitochondrial energy metabolism
in G3 ntESCs and WT ESCs, G3 iPSCs exhibit aberrant mito-
chondrial function with a lower respiration capacity but give
rise to ROS overproduction, which, in turn, is associated with
an increased mtDNA mutation frequency.
Mitochondrial Dysfunction in G3 iPSCs Is Independent
of PGC Network Repression
In Terc/ somatic cells, mitochondrial dysfunction is caused by
the telomere-p53-PGC axis (Sahin et al., 2011), which prompted
us to analyze the PGC network in G3 iPSCs and ntESCs. Surpris-
ingly, PGC-1a and PGC-1b were not repressed in G3 ntESCs
and iPSCs compared with WT ESCs (Figure 6A). The expression
levels of the PGC network’s major downstream targets, ERR,
TFAM, and NRF-1, in G3 ntESCs and iPSCs were not reduced
but were increased comparedwithWT ESCs (Figure 6B). In addi-
tion, mitochondrial DNA content was maintained or even slightly
increased in G3 iPSCs and G3 ntESCs (Figure 6C). The above
data suggest that mitochondrial dysfunction in G3 iPSCs and
G3 ntESCs is independent of PGC network repression.
Next, we questioned whether mitochondrial dysfunction de-
pends on p53 activation. Treating G3 iPSCs with p53 small inter-
fering RNA (siRNA) decreased ROS levels, suggesting that ROS
generation partially depends on p53 (Figures S6A and S6B). It is
known that p53 can enhance ROS generation enzymes to in-
crease cellular ROS levels. Proline oxidase, a p53 target gene
that regulates ROS generation (Donald et al., 2001), was upregu-
lated in G3 iPSCs (Figure S6C). siRNA-mediated knockdown of
proline oxidase reduced ROS levels (Figures S6D and S6E), indi-
cating that ROS accumulation in G3 iPSCs partially depends on
p53 activation of the ROS-generating enzyme.
Impaired Neuroectoderm Differentiation in G3 iPSCs Is
Associated with Mitochondrial Maturation Defect
It has been shown that the increased embryo lethality of Terc/
mice is associated with defects in neuroectodermalCell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc. 33
Figure 5. G3 ntESCs Show Alleviated Mitochondrial Dysfunction Compared with G3 iPSCs
(A) Gene ontology analysis based on cell components of the differentially expressed genes between G3 ntESCs and G3 iPSCs from the microarray data. David
Bioinformatics Resources were used to cluster genes from the microarray data. Clustering with p < 0.05 was selected.
(B) Oxygen consumption rates (OCRs) in WT ESCs, G2-G3 ntESCs and iPSCs treated sequentially with oligomycin, FCCP, antimycin, and rotenone. (Mean ± SD;
n = 3; cell passage = 10.)
(C and D) Basal and maximal OCRs as described in (B). (Mean ± SD; n = 3; Student’s t test; ***p < 0.001; cell passage = 10.)
(E) Relative ATP content quantification using a luciferin/luciferase-based ATP bioluminescence assay. The ATP content in WT ESCs was set as 1 (mean ± SD;
n = 3; Student’s t test; *p < 0.05; cell passage = 10).
(F) Representative electron microscopy images indicating mitochondrial morphology in WT ESCs, G3 ntESCs and iPSCs. Mitochondria are indicated by arrows
(n = 3; cell passage = 10). Scale bars, 0.5 mm.
(G) Left: the ROS levels of G3 ntESCs andG3 iPSCs using flow cytometry. Right: the relative ROS levels inWT ESCs, G2-G3 TTFs, andG2-G3 ntESCs, and iPSCs.
The relative ROS level of G3 TTFs is set as 1 (mean ± SD; n = 3; Student’s t test; ***p < 0.001; cell passage = 10).
(H) Summary of mitochondrial DNA (mtDNA) mutations in G3 ntESCs and iPSCs. mtDNA was divided into six regions, and each region was amplified by PCR.
A total of 15 individual sequences for each region were subjected to sequencing. The primers used are listed in Table S4.
See also Figure S5 and Table S4.
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Telomere Rejuvenation by SCNTdifferentiation (Herrera et al., 1999a; Lee et al., 1998). In addition,
mitochondrial dysfunction has been shown to play a key role in
the pathogenesis of many neurodegenerative diseases (Costa
and Scorrano, 2012; Exner et al., 2012). To assess the impact34 Cell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc.of mitochondrial dysfunction on the neuroectodermal differenti-
ation ability of G3 iPSCs and ntESCs, we performed in vitro
differentiation oriented to neuronal progenitor cells in the
presence of RA using WT ESCs, G3 ntESCs, and G3 iPSCs.
Figure 6. Dysfunctional Mitochondria in G3 iPSCs Are Independent of PGC Network Repression
(A and B) Relative mRNA expression is normalized to b-actin mRNA and is represented relative to expression in WT ESCs as a control, set at 1 (mean ± SD; n = 3;
Student’s t test; *p < 0.05, ***p < 0.001; cell passage = 15). (A) Quantitative PCR analysis shows upregulation ofPGC-1a andPGC-1b in G3 ntESCs andG3 iPSCs.
(B) Quantitative PCR analysis shows expression of the PGC network’s downstream targets in G3 ntESCs and G3 iPSCs.
(C) The relative mtDNA content in G3 ntESCs and G3 iPSCs by quantitative PCR analysis (mean ± SD; n = 3; Student’s t test; *p < 0.05, **p < 0.01; cell
passage = 15).
See also Figure S6.
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Telomere Rejuvenation by SCNTEBs derived from G3 iPSCs grew substantially more slowly, and
the EB formation ability of G3 iPSCs was markedly reduced
compared with that of WT ESCs, whereas these defects were
significantly mitigated in G3 ntESCs (Figures 7A and 7B). After
plating EBs on PDL/laminin-coated cell culture dishes, we ob-
served cells migrating quickly from adherent EBs derived from
WT ESCs and G3 ntESCs and the formation of radial structures
with long fibers (Figure S7A). However, we did not observe such
transformation of EBs derived from G3 iPSCs. After 5 days of
culture under neuron differentiation conditions, neuronal pro-
genitor spheres were generated from WT ESCs and G3 ntESCs,
while neuronal progenitor cells failed to arise fromG3 iPSCs (Fig-
ures 7C and S7B).
During differentiation, mitochondrial biogenesis and matura-
tion through the activation of the PGC network occur for a
more efficient energy production, shifting from glycolysis to the
mitochondria (Facucho-Oliveira and St John, 2009). To evaluate
this process, we harvested cells migrating from EBs under
neuron differentiation culture conditions for 5 days. The mito-
chondrial content notably increased in cells derived from WT
ESCs and G3 ntESCs, while no increase was observed in cells
derived fromG3 iPSCs (Figure 7D). Consistent with these results,
PGC-1a expression was highly upregulated in WT ESCs and G3
ntESCs, whereas PGC-1a expression remained very low in G3
iPSCs (Figure 7E). In addition, the ATP content in cells derived
from G3 iPSCs showed a dramatic decrease compared with
G3 ntESCs (Figure 7F). In summary, G3 ntESCs display an
enhanced neuroectodermal differentiating capability accompa-
nied with alleviated mitochondrial defects and a sufficient reac-
tivation ability of PGC-1a compared with G3 iPSCs.To test whether the PGC-1a overexpression could rescue the
impaired neuroectodermal differentiation in G3 iPSCs, we estab-
lished inducible PGC-1a overexpression in G3 iPSCs by electro-
poration delivery of linear pVgRXR and pIND-PGC-1a vectors.
As shown in Figure 7G, overexpression of PGC-1a increased
mitochondria content in EBs derived from G3 iPSCs. Accompa-
nied with the mitochondria content increase, EB formation effi-
ciency was also markedly improved (Figure 7H). However, only
a small amount of these EBs formed radial structures with long
fibers and generated neuron progenitor cells (Figures S7C and
7I). Neuron progenitor cells derived from G3 iPSCs grew very
slowly and were passaged every 6–7 days while neuron progen-
itor cells derived from WT ES and G3 ntESCs were passaged
every 3–4 days. The incomplete rescue of the impaired differen-
tiation of G3 iPSCs by PGC-1a overexpression suggests other
downstream effects of telomerase deficiency or that irreversible
mitochondrial damage such as mitochondria mutations may
hamper this process. In summary, these data suggest that the
mitochondrial biogenesis defect and compromised energy pro-
duction are associated with the impaired neuroectodermal
differentiation capability of G3 iPSCs, which can be partially
rescued by PGC-1a overexpression.
DISCUSSION
Telomere shortening and mitochondrial dysfunction are closely
linked with degenerative pathogenesis in human. Reversion of
telomere dysfunction and mitochondrial defects of patients has
been considered crucial for the acquisition of authentic pluripo-
tency by somatic cell reprogramming. Here, we utilized somaticCell Stem Cell 14, 27–39, January 2, 2014 ª2014 Elsevier Inc. 35
Figure 7. Impaired In Vitro Differentiation Capacity of G3 iPSCs Is Associated with Failure of PGC-1a Reactivation
D-wtES, D-G3ntES2#, D-G3ntES5#, D-G3iPS5#, and D-G3iPS15# mean the differentiating cells derived from corresponding parental cells under the neuro-
ectodermal differentiation conditions. N-wtES, N-G3ntES2#, N-G3ntES5#, N-G3iPS5#, and N-G3iPS15# indicate the neuron progenitor cells derived from
corresponding parental cells.
(A) Representative images showing EB morphology 4 days after WT ESCs, G3 ntESCs, and G3 iPSCs were subjected to in vitro neuroectodermal differentiation
conditions. Scale bar, 100 mm.
(B) EB number (per 4 3 104 cells) was calculated 5 days after WT ESCs, G3 ntESCs, and G3 iPSCs were subjected to in vitro neuroectodermal differentiation
conditions (mean ± SD; n = 3; Student’s t test; **p < 0.01, ***p < 0.001; cell passage = 15).
(C) Images of neuron spheres generated from WT ESCs and G3 ntESCs. Scale bar, 100 mm.
(D) Relative mtDNA content of EBs 5 days after WT ESCs, G3 ntESCs, and G3 iPSCs were subjected to in vitro neuroectodermal differentiation conditions by
quantitative PCR analysis (mean ± SD; n = 3; Student’s t test; ***p < 0.001; cell passage = 15).
(E) Quantitative PCR analysis shows PGC1-a expression in EBs 5 days after WT ESCs, G3 ntESCs, and G3 iPSCs were subjected to in vitro neuroectodermal
differentiation conditions. Relative mRNA expression is normalized to b-actin mRNA and is represented relative to expression in undifferentiated WT ESCs as a
control, set as 1 (mean ± SD; n = 3; Student’s t test; ***p < 0.001; cell passage = 15).
(F) The relative ATP content quantification 10 days afterWT ESCs, G3 ntESCs, andG3 iPSCswere subjected to in vitro neuroectodermal differentiation conditions
(mean ± SD; n = 3; Student’s t test; ***p < 0.001; cell passage = 15).
(G) Relative mtDNA content of EBs 5 days after in vitro neuroectodermal differentiation of G3 iPSCs (mean ± SD; n = 2; Student’s t test; ***p < 0.001; cell
passage = 15). Overexpression ofPGC-1awas induced by 10 mMPonasterone A. Equal volume of Dimethyl sulfoxide (DMSO, 0.1%) was added in the culture as a
control (the vehicle in which Ponasterone A is dissolved).
(H) EB number (per 43 104 cells) was calculated 5 days after in vitro neuroectodermal differentiation of G3 iPSCs (mean ± SD; n = 2; Student’s t test; *p < 0.05; cell
passage = 15). G3 iPSCs were treated with 10 mM Ponasterone A or equal volume of DMSO (0.1%).
(legend continued on next page)
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Telomere Rejuvenation by SCNTcells of telomerase-deficient mice as a model to compare the re-
programming competency mediated by SCNT and transcription
factors. Interestingly, Terc/ ntESCs show more enhanced dif-
ferentiation potential and better self-renewal ability than Terc/
iPSCs, and these observations are associated with improved
mitochondrial and telomere function.
Telomere elongation is of great importance for the acquisition
of pluripotency during reprogramming. Telomere lengthening
during iPSC induction mainly relies on telomerase, the action
of which is a very time consuming process, and iPSC telomeres
need postreprogramming to reach the length resembling that of
ESCs (Marion et al., 2009b; Wang et al., 2012). In this study, we
have shown that telomeres elongate markedly in cloned em-
bryos reconstructed with telomerase-deficient somatic cells,
leading to improved telomere capping function in the established
ntESC lines. In contrast, in transcription-factor-mediated re-
programming, telomere function becomes further impaired in
the absence of telomerase, although the average telomere
length maintains or slightly increases. Our study indicates that
the telomerase-independent mechanism is substantially more
effective in SCNT than in iPSCs. Elucidating the factors involved
in telomere lengthening via the ALT mechanism in SCNT or early
embryos might greatly benefit the iPSC induction. This notion is
supported by some recent studies on Zscan4. This gene specif-
ically marks two cell-embryo and ESCs (Falco et al., 2007; Zalz-
man et al., 2010). The transient expression of Zscan4 in ESCs is
associated with rapid telomere elongation (Zalzman et al., 2010).
Addition of Zscan4 in the iPSC induction process efficiently elon-
gates telomeres and enhances the portion of iPSCs with the
ability to generate full-term mice (Jiang et al., 2013). It remains
elusive if the combination of Zscan4 with Yamanaka factors is
sufficient to reprogram somatic cells with limited telomere
reserve such as somatic cells of late generation Terc/ mice.
Obviously, future studies related to the above question will
contribute to the improvement of iPSCs, particularly from
patients with telomere or telomerase defects.
Recently, a link between dysfunctional telomeres and im-
paired mitochondria has been uncovered in somatic and cancer
cells (Hu et al., 2012; Sahin et al., 2011). In fact, we observed
further mitochondrial impairment in G3 iPSCs, which prompted
us to evaluate the association of PGC-1a gene expression with
mitochondrial quality in our system. Previous studies have
shown that the expression level of PGC-1b increases as an
adaptive mechanism in telomerase-deficient cancer cells to alle-
viate the mitochondrial dysfunction caused by telomere attrition
(Hu et al., 2012). Interestingly, both G3 ntESCs and iPSCs have
been shown to upregulate PGC-1a and PGC-1b expression
levels compared with WT ESCs, while dramatic differences in
mitochondrial function were still evident between G3 ntESCs
and iPSCs. It is plausible that irreversible mitochondrial damage
caused by PGC repression may accumulate in the Terc/
somatic cells, which cannot be restored completely simply
through an adaptive upregulation of the PGC network. In
contrast, the ntESC mitochondria were derived from both(I) Images of neuron spheres generated from G3 iPSCs in which PGC-1a is over
(J) Quantitative PCR analysis shows expression of neuron progenitor cell markers
iPSCs (mean ± SD; n = 2; Student’s t test; ***p < 0.001; cell passage = 2).
See also Figure S7.somatic cells and recipient oocytes, and the healthier mitochon-
dria from oocytes may improve the overall metabolism compe-
tence and lessen the ROS damage. Moreover, telomere attrition
is more deleterious in G3 Terc/ iPSCs compared with ntESCs,
which may suppress mitochondrial function via a PGC-indepen-
dent mechanism, as previous work has shown that the effects
imposed by p53 activation onmitochondrial function are context
dependent (Bae et al., 2005; Matoba et al., 2006). Indeed, we
have found that proline oxidase, a p53-targeted ROS generation
enzyme, is upregulated in G3 iPSCs and that inhibition of proline
oxidase can partially decrease ROS levels, indicating a p53-
dependent but PGC-independent network in suppressing G3
iPSC mitochondrial function.
In summary, our study demonstrates that SCNT is superior to
transcription factors in reprogramming somatic cells with telo-
mere and mitochondria defects. The breakthrough recently
achieved in human SCNT studies further suggests that the iden-
tification of novel reprogramming factors might greatly improve
the current iPSC technology and enhance the quality of human
iPSCs derived particularly from patients with telomere and mito-
chondria defects (Sancho-Martinez and Izpisua Belmonte, 2013;
Tachibana et al., 2013).
EXPERIMENTAL PROCEDURES
Real-Time PCR-Based Quantification of mtDNA Copy Number and
mtDNA Sequencing
Total DNA was isolated using Nucleaspin (MACHEREY-NAGEL, Du¨ren,
Germany) and then subjected to real-time PCR as previously described (Sahin
et al., 2011). For mtDNA sequencing, total DNA was isolated as described
above following PCR amplification using primers directed against mtDNA
and Phusion High Fidelity PCR Master MIX with HF Buffer (New England
Biolabs). The PCR-amplified fragments were cloned into vectors in the
pEASYTM-T5 Zero Cloning Kit (TransGen Biotech). mtDNA was divided into
six regions for PCR amplification and was subjected to sequencing. For
each region, 15 randomly selected clones were sequenced. All primers used
are listed in Table S4.
Cell Growth Curve, BrdU Assay, and Apoptosis Analysis
For growth curve analysis, a total of 5 3 105 cells were plated onto 35 mm
dishes, and the cells were harvested every 24 hr and counted with a cell
counting chamber. Each group contained three replicates. For BrdU
incorporation assay, pluripotent stem cells were treated with BrdU for
30 min. The cells were stained following the manufacturer’s instructions
(FITC BrdU Flow Kit, BD). For cell apoptosis detection, 5 3 105 pluripotent
stem cells were plated onto 35 mm dishes, and 3 days later, the attached
cells were harvested using 0.05% trypsin along with the cells in suspension.
Staining was performed according to the manufacturer’s instructions
(DeadEnd Fluorometric TUNEL system, Promega). Quantification of BrdU-
and TUNEL-positive cells was performed using FACS with standard proce-
dures (Moflo).
Q-FISH and Real-Time-PCR-Based Measurement of Telomere
Length
FISH for telomeric DNA was performed with a Cy-3-labeled PNA probe
(PANAGENE, Daejeon, Korea) as previously described (Sfeir et al., 2009).
For real-time-PCR-based measurement of telomere length, total DNA was
extracted from approximately 15 blastocysts or pluripotent stem cellsexpressed. Scale bar, 100 mm.
including Pax6,Nestin, and Sox2 in the neuron progenitor cells derived fromG3
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Telomere Rejuvenation by SCNTusing the QIAamp DNA Micro Kit (QIAGEN). The acidic ribosomal phos-
phoprotein PO (36B4) gene was used as the endogenous control. The
primers and reaction conditions were as previously described (Callicott
and Womack, 2006).
OCR and ECAR Measurements Using the Seahorse Cellular Flux
Assay
A total of 5–10 3 104 pluripotent stem cells were seeded 24 hr before mea-
surement by the XF24 Seahorse instrument. For bioenergetic profile analysis,
oligomycin (1 mg, Sigma), FCCP (1.5mM,Sigma), and antimycin (1 mM,Sigma) +
rotenone (1 mM, Sigma) were sequentially injected into the XF24 assay
medium. The XF24 Seahorse instrument was utilized following the manufac-
turer’s instructions, and the reactions were performed in triplicate.
ATP Content and ROS Assay
Total cellular ATP was measured using Mitochondrial ToxGlo (Promega) using
an EnSpire Multimode Reader (PerkinElmer). Cellular ROS level was detected
with 2,7-dichlorofluorescein diacetate (DCFH-DA, Beyotime).
Electron Microscopy of Cellular Mitochondria
Cultured cells were scraped from dishes and loaded into the 50-mm-deep side
of a 50 mm/250 mm aluminum specimen carrier, filled with hexadecene to
exclude any air bubble, then sandwiched against the flat side of a 300 mm
specimen carrier (Cat.No.390, Cat.No.242 for the two carriers, Engineering
Office M. Wohlwend GmbH; Sennwald, Switzerland) and immediately rapid-
frozen with HPF Compact 01 high pressure freezing machine (Engineering
Office M. Wohlwend GmbH) at 2,100 bar high pressure. The frozen samples
were transferred to 1.5 ml microcentrifuge tubes (Fisher Scientific, USA) con-
taining a frozen solution of acetone with 1% OsO4 and 0.1% uranyl acetate
under liquid nitrogen. Tubes were placed in a Leica EM AFS machine (Leica
Microsystems, Wetzlar, Germany) at 90C. The temperature was then grad-
ually raised in 6 hr transitions in the Leica AFS system as follows:90C for 24–
48 hr, 60C for 24 hr, and 30C for 18 hr. After slowly being warmed to 4C
over 2 hr, samples were washed three times in pure acetone and warmed to
room temperature. The specimens were infiltrated, embedded, polymerized,
sectioned, and stained as previously described (He et al., 2003). We examined
90 nm thin sections using an FEI Tecnai G2 Spirit Twin electron microscope
operating at 120 kV, and projection images were recorded on a Gatan 895
4 K 3 4 K CCD camera (Gatan Corporation, Pleasanton, CA, USA).
Microarray Analysis
After removal of the feeder cells, total RNA was extracted. The Affymetrix
Mouse Gene 1.0 ST Array (Affymetrix, Inc.) was performed at the Beijing
CapitalBio Corporation. The multiple tests were adjusted with FDR methods
(BH95, R p.adjust command), and a cutoff of FDR % 0.05 was chosen as
the criterion for significance.
Mice
All of our study procedures were consistent with those in the National Institute
of Biological Sciences guide for the care and use of laboratory animals.
Statistical Analysis
Results were represented as the mean ± SD of independent experiments. Sig-
nificancewasdeterminedwithStudent’s t testsusingGraphPadPrismsoftware.
ACCESSION NUMBERS
The microarray data sets have been deposited in NCBI’s Gene Expres-
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